Immunomodulating drugs

General description Bcl-X has two isoforms, Bcl-XL (long), a 241-aa protein, and Bcl-XS (short), a 178-aa protein lacking a 63 aa domain that is well conserved among members of the Bcl-2 family. Specificity MAB4625 recognizes a protein of 27

ANTI-BCL-XL ANTIBODY CLONE 2V10G9 RABBIT MONOCLONAL

General description Bcl-X consists of two isoforms, Bcl-XL (long), a 241 aa protein, and Bcl-XS (short), a 178 aa protein lacking a 63-aa domain that is well conserved among members of the Bcl-2 family. Bcl-XL represses cell death, while Bcl-XS

General description Anti-BCL-XL Antibody detects endogenous levels of total BCL-XL protein. Immunogen The antiserum was produced against synthesized peptide derived from human BCL-XL.

ANTI-BCL10 ANTIBODY CLONE 8H7A5 RABBIT MONOCLONAL

General description This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis

General description BCL2 (B-cell lymphoma 2) consists of pro- and antiapoptotic functions. It belongs to BCL2 family of proteins.

Immunogen Peptide sequence around aa. 68-72 (R-T-S-P-L), according to the protein BCL2.

BCL2 is an apoptotic inhibitor that suppresses lipid peroxidation. Rabbit Anti-BCL2 antibody binds to human BCL2.

Immunogen B-cell CLL/lymphoma 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

Immunogen Peptide with sequence NVVSVDTART, from the internal region of the protein sequence according to NP_004040.1: NP_001108207.

Immunogen A 14 amino acid peptide from near the amino terminus of human Bfl-1. Features and Benefits Evaluate our antibodies with complete peace of mind.